Takeda has a variety of resources to help patients who have been prescribed FEIBA®, including information, guidance, and resources regarding their treatment. Talk to your healthcare provider about your goals for treatment.

FREEDOM OF CHOICE™

Ask your healthcare provider if you may be eligible to receive 15 free doses of FEIBA. This Free Trial Program is for new FEIBA patients only. Participants must receive consultation and approval from a healthcare provider.

Download registration form

Hematology Support Center

Takeda's Hematology Support Center (HSC) is dedicated to helping patients who have been prescribed Takeda hematology products and healthcare providers who have a patient on or ready to start on a Takeda hematology product. HSC offers help with treatment access, as well as educational resources and information on financial assistance programs.
Call 1-888-229-8379 Monday—Friday 8:30AM—8:00PM (ET).

Visit HematologySupport.com

If you have been prescribed FEIBA, here are a few ways that the HSC can help:

  • Case managers checklist icon.

    Case Managers

    A point of contact who is ready to assist you with accessing your treatment

  • Copay assistance icon.

    CoPay Assistance

    For eligible commercially insured Takeda patients, Takeda's CoPay Assistance Program covers out-of-pocket expenses related to a patient's Takeda Hematology treatment for which there is a co-pay, such as deductibles and coinsurances.†‡§

  • Patient Access Manager icon.

    Patient Access Manager

    A Patient Access Manager is available and can provide one-on-one, personalized insurance education and access information

  • Resources and Education icon.

    Resources and Education

    Connecting you and your caregiver with educational resources ‐ including a Healthcare Educator who can work with you one-on-one if needed

  • Must meet specific program eligibility requirements and terms and conditions. Certain restrictions apply. Not all Takeda hematology products are available for each program.
  • These programs are not valid for prescriptions reimbursed, in whole or in part by Medicaid, Medicare, Medigap, VA, DoD, TRICARE or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by health insurance provider or by law. Offer good only in the United States. Offer void where prohibited by law, taxed, or restricted. Takeda reserves the right to rescind, revoke or amend each offer at any time without notice.
  • § Non-medication expenses, such as ancillary supplies or certain/some administration-related costs, are not eligible.
Target board icon: Set realistic goals with the help of your healthcare provider

SET YOUR GOALS

This simple worksheet helps you work with your healthcare provider to create realistic goals and a plan to reach them.

Goals worksheet
Calendar icon: Keep a log of your infusion and vial treatments

KEEP AN INFUSION LOG

Streamline your infusion log and vital records into one document.

Infusion log
Checklist icon: Follow these steps to reduce complications of hemophilia

DO THE 5!

Check out the tips from the National Prevention Program, a collaboration between NHF, Centers for Disease Control and Prevention, HTCs, and member of the bleeding conditions community24.

They may help you prevent or reduce the complications of hemophilia

  1. Get a comprehensive checkup every year
  2. Get vaccinated (and keep your vaccinations up to date)
  3. Treat bleeds early and adequately
  4. Protect your joints by exercising regularly and maintaining a healthy weight
  5. Get tested regularly for blood-borne infections

Always talk with your doctor for advice and guidance on health matters.

Sign up
Location pin icon: Locate a hemophilia treatment center

LOCATE AN HTC

Hemophilia Treatment Centers, or HTCs, are specialized healthcare centers staffed by health professionals experienced in treating hemophilia. They're located coast to coast.

Find an HTC
See LessMore

What is FEIBA?

FEIBA is an Anti-Inhibitor Coagulant Complex approved for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes

Detailed Important Risk Information

What is FEIBA?

FEIBA is an Anti-Inhibitor Coagulant Complex approved for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Use around the time of surgery
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes

Detailed Important Risk Information

  • Blood clots that block blood vessels and their effects have been reported during post-marketing surveillance following infusion of FEIBA, particularly following administration of high doses (above 200 units per kg per day) and/or in patients at risk for forming blood clots.
  • If you experience any of these side effects, call your doctor right away.